Thrivelab

Thrivelab

Growth Stage

Profitable, AI-powered healthcare company focused on hormone health, nutrition and mental well-being

Profitable, AI-powered healthcare company focused on hormone health, nutrition and mental well-being

Overview

Raised this Round: Raised: $81,650

Total Commitments ($USD)

Platform

Wefunder

Start Date

08/28/2024

Close Date

12/13/2024

Min. Goal
$50,000
Max. Goal
$615,850
Min. Investment

$100

Security Type

Equity - Preferred

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$5,477.00

Pre-Money Valuation

$20,000,000

Year Founded

2020

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2C

Margin

Medium

Capital Intensity

Low

Location

San Clemente, California

Business Type

Growth

Thrivelab, with a valuation of $20 million, is raising funds on Wefunder. The company has developed a concierge hormone health program to help people with hormonal imbalances. Thrivelab’s platform offers self-assessment for patients to onboard, followed by an initial consult and a patent-pending blend of treatment protocols, nutraceuticals, and technology. The business works on a recurring revenue model and has reported a 206% year-over-year revenue growth with 63% gross margins. Joshua Host, Dr. Nayan Patel, Dr. Ryan Jones, and Rahula Kochar founded Thrivelab in July 2020. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $615,850. The campaign proceeds will be used for marketing, product improvement, IT, and the launch of new channels.

Summary Profit and Loss Statement

FY 2023 FY 2022

Revenue

$5,370,196

$1,832,582

COGS

$2,133,754

$932,036

Tax

$0

$10,906

 

 

Net Income

$-2,533,143

$-3,504,170

Summary Balance Sheet

FY 2023 FY 2022

Cash

$56,881

$184,622

Accounts Receivable

$4,167

$10,376

Total Assets

$184,886

$256,192

Short-Term Debt

$4,928,287

$613,334

Long-Term Debt

$0

$3,900,000

Total Liabilities

$4,928,287

$4,513,334

Financials as of: 08/28/2024
Create a free account today to gain access to Kingscrowd analytics.

Raise History

Offering Name Close Date Platform Valuation Total Raised Security Type Status Reg Type
Thrivelab 12/13/2024 Wefunder $20,000,000 $81,650 Equity - Preferred Active RegCF
Thrivelab 04/30/2023 Wefunder $17,250,000 $108,590 SAFE Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Thrivelab on Wefunder 2024
Platform: Wefunder
Security Type: Equity - Preferred
Valuation: $20,000,000
Price per Share: $5.00

Follow company

Follow Thrivelab on Wefunder 2024

Buy Thrivelab's Deal Report

Thrivelab Deal Report

Get Kingscrowd's comprehensive report on Thrivelab including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Thrivelab is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Thrivelab deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge